Jingyue Yao

563 citations
7 papers · 333 indexed · 1 hit paper · h-index 6
Topics
Autophagy in Disease and Therapy (3 papers)Cancer, Lipids, and Metabolism (2 papers)Cancer, Hypoxia, and Metabolism (2 papers)
Partner nations
ChinaTaiwan

In The Last Decade

Jingyue Yao

7 papers receiving 331 citations

Hit Papers

CDK9 inhibition blocks the initiation of PINK1-PRKN-media...2021202620222024202150100150

Peers

Jingyue Yao
Comparison fields: 5 of 66
  • Molecular Biology 209
  • Epidemiology 99
  • Cancer Research 99
  • Pharmacology 41
  • Oncology 38
Replace Xinhui Kou with:
Xinhui Kou China
Bu‐Shan Xie China
Yijia Feng China
Sebastiano Andò Italy
Manhua Chen China
Xiao-Qi Wu China
Hali Li China
Bhupender Kumar India
Boxian Zhao China
Jingyue Yao relative to Xinhui Kou China Xinhui Kou's profile →
Citations per field
00.5×1.6×
Xinhui Kou · 1×
Citations per year

Countries citing papers authored by Jingyue Yao

Since Specialization
Citations

This map shows the geographic impact of Jingyue Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyue Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyue Yao more than expected).

Fields of papers citing papers by Jingyue Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingyue Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyue Yao. The network helps show where Jingyue Yao may publish in the future.

Co-authorship network of co-authors of Jingyue Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Jingyue Yao. A scholar is included among the top collaborators of Jingyue Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingyue Yao. Jingyue Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 2
2 41
3
CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinomabreakdown →
155
4 12
5 43
6 74
7 6

About Jingyue Yao

Jingyue Yao is a scholar working on Geriatrics and Gerontology, Cancer Research and Pharmacology, having authored 7 papers that have together received 333 indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (3 papers), Cancer, Lipids, and Metabolism (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Geriatrics and Gerontology (28 citations), Cancer Research (99 citations) and Physiology (17 citations). Jingyue Yao has collaborated with scholars based in China and Taiwan. Frequent co-authors include Libin Wei, Qinglong Guo, Ye Xu, Yuening Sun, Zihao He, Yongjian Guo, Jubo Wang, Jian Liu, Ting Ni and Yuanyuan Dai. Their work appears in journals such as Molecules, Autophagy and Cell Death and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026